First Manhattan CO Immunocore Holdings PLC Transaction History

First Manhattan CO

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 14, 2023	SELL	$45.51 - $65.08 $8.29 Million - $11.9 Million	-182,100 Reduced 22.88%	613,749 $35 Million
Q2 2022 Aug 15, 2022	SELL	$25.46 - $37.72 $323,342 - $479,044	-12,700 Reduced 1.57%	795,849 $29.7 Million
Q1 2022 May 16, 2022	BUY	$18.94 - $34.29 $5.66 Million - $10.2 Million	298,693 Added 58.58%	808,549 $24.2 Million
Q4 2021 Feb 14, 2022	BUY	$27.58 - $40.0 $8.6 Million - $12.5 Million	311,857 Added 157.5%	509,856 $17.5 Million
Q3 2021 Nov 15, 2021	BUY	$27.98 - $40.0 $5.54 Million - $7.92 Million	197,999 New	197,999 $7.34 Million

141

41.4M

197K

451K

Ticker IMCR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 43,897,100
Market Cap $1.24B
Description
Immunocore Holdings plc, a commercial-stage biotechnology company, engages in the development of immunotherapies for the treatment of cancer, infectious, and autoimmune diseases. The company offers KIMMTRAK for the treatment of patients with unresectable or metastatic uveal melanoma. Its other programs for oncology comprise IMC-C103C that is in ...

Get notified when there are updates to the investment portfolio of First Manhattan CO, based on Form 13F filings with the SEC.

Stay updated on First Manhattan CO with notifications on news.